Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Payables: 2011-2024

Historic Payables for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $7.4 million.

  • Mimedx Group's Payables rose 64.86% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.2 million, marking a year-over-year increase of 8.77%. This contributed to the annual value of $7.4 million for FY2024, which is 18.11% down from last year.
  • Latest data reveals that Mimedx Group reported Payables of $7.4 million as of FY2024, which was down 18.11% from $9.0 million recorded in FY2023.
  • Mimedx Group's Payables' 5-year high stood at $9.0 million during FY2023, with a 5-year trough of $7.4 million in FY2021.
  • Over the past 3 years, Mimedx Group's median Payables value was $8.5 million (recorded in 2022), while the average stood at $8.3 million.
  • Per our database at Business Quant, Mimedx Group's Payables climbed by 14.48% in 2022 and then declined by 18.11% in 2024.
  • Yearly analysis of 5 years shows Mimedx Group's Payables stood at $8.8 million in 2020, then dropped by 15.74% to $7.4 million in 2021, then grew by 14.48% to $8.5 million in 2022, then increased by 7.03% to $9.0 million in 2023, then dropped by 18.11% to $7.4 million in 2024.